Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 9.50 |
| PEG Ratio (TTM) | N/A | -142.71 |
| P/S Ratio (TTM) | 0.01 | 0.49 |
| P/B Ratio (TTM) | N/A | 1.42 |
| P/FCF Ratio (TTM) | 0.54 | 14.13 |
| Price to 5YR AVG Earnings Ratio | N/A | 13.34 |
| Price to 5YR AVG FCF Ratio | 0.40 | 66.34 |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.87% | 4.09% |
| ROE (TTM) | 11.85% | 3.35% |
| Net Profit Margin (TTM) | 3.21% | 0.38% |
| ROIC 5YR AVG | 13.20% | 11.41% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -25.00% | -66.67% | -60.00% |
| Revenue | 411.66% | 1,749.69% | 1,436.38% |
| Net Income | 115.96% | 1,231.48% | 1,048.89% |
| Cash Flow | 1,071.14% | 1,263.93% | 1,126.49% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.62 | 1.96 |
| Quick Ratio (TTM) | 0.93 | 1.16 |
| D/E Ratio (TTM) | 0.20 | 0.54 |
| Interest Coverage (TTM) | 7.59 | 5.29 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.36 | 3.65 |
| LTL to 5YR AVG FCF | 1.92 | 17.04 |
| Shares Outstanding Growth 5YR AVG | -60.00% | -6.82% |